Clinical Trial

PULSTA TPV Observational Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine the long-term follow-up clinical outcomes, effectiveness, and safety data of the PULSTA Transcatheter Pulmonary Valve (TPV) implantation in a real-world situation
Trial Details
NCT Number NCT07747207
Lead Sponsor Taewoong Medical Co., Ltd.
Collaborators: Avania
Conditions Heart Disease
Enrollment 200 participants
Start Date 2026-10
Primary Completion 2028-07 (estimated)
Study Completion 2033-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-10